Home Ideas & Research Indexes Hedge Funds Portfolios My tickerspy Newswire
Enter ticker(s) QQQ: 73.45 -0.23%   SPY: 165.45 -0.29%
Quote Spy RPRX NEW Message Board  
Click to close X

Visit a stock's Spy page to see who else is tracking it and who else is talking about it. Spy pages also list institutional holders.


Repros Therapeutics (RPRX)

@ May-23
Click the portfolio to add RPRX:
Close [X]
+ Add RPRX to Portfolio
  
  Last Trade: $15.82 +0.32 (2.06%)
  Volume: 270,739 61% of avg daily volume
       
  Avg Volume: 441,180
3-Month Chart (Larger chart w/volume)
Close [X]
1m  3m  6m  1y  2y
  Day's Range: 15.11 - 16.00
  Open: 15.49
  Previous Close: 15.50
  52-wk Range: 7.55 - 20.78
  Market Cap: 288.9M
  P/E: -10.9
  Div Yield: $0.00 (0.00%)
Indexes
Biotechnology Stocks (+1.1%)
Spy RPRX

? Pro holders
? Member holders
? Items submitted
Additional RPRX resources



Customize Links
To see which Pros and tickerspy members own RPRX Sign up now
Latest RPRX Notes & Links
View: Headlines   |   Message Board   |   Portfolio Notes  

Market Close: Big Winners & Losers for March 28, 2013
GV  RPRX  HDSN  LIVE  GAI  HIMX  PAMT  MCOX  NMAR  SXE  
Linked by 24/7 Wall St. - March 28, 04:27PM from (247wallst.com)
Here are today’s five biggest gaining stocks at closing: Repros Therapeutics Inc. (NASDAQ: RPRX) is up 76.3% at $16.10.  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Repros Gains as Androxal Meets Testosterone Study Goals
RPRX  
Linked by Bloomberg - March 28, 11:10AM from (www.bloomberg.com)
Repros Therapeutics Inc., (RPRX) maker of an experimental drug to restore normal testosterone levels to men with hypogonadism,  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Market Wrap for Thursday, February 21: Stocks Fall For Second Day
SWY  BRY  QCOM  SPY  RPRX  RFMD  PRKR  PAY  LINE  UUP  TLT  
Linked by Benzinga.com - February 21, 04:18PM from (www.benzinga.com)
The stock market continued to undergo a correction on Thursday, although losses were contained. Investors are worried about  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
24/7 Wall St. Closing Bell — February 21, 2013: Markets Turn South Early
AIG  FTR  HPQ  JWN  SWY  WMT  CDE  ESV  NKE  UNH  PAAS  QCOM  BHP  WLT  CHK  RPRX  PRKR  EGO  AGU  ETP  ANF  MRVL  NEM  AUY  GOOG  PAY  CROX  TSLA  GRPN  CG  
Linked by 24/7 Wall St. - February 21, 04:03PM from (247wallst.com)
U.S. equity markets opened lower this morning and continued a slow downward slide throughout the day. In Europe, flash PMI  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Repros Blasts Off After FDA Study Clearance
RPRX  
Linked by 24/7 Wall St. - February 21, 08:15AM from (247wallst.com)
Repros Therapeutics Inc. (NASDAQ: RPRX) is surging on clinical update news this Thursday. The company's Androxal Phase 3  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Repros Therapeutics Corporate Update
RPRX  
Linked by GlobeNewswire - February 11, 09:43AM from (globenewswire.com)

THE WOODLANDS, Texas, Feb. 11, 2013 (GLOBE NEWSWIRE) -- Repros Therapeutics Inc.® (Nasdaq:RPRX) today provided an  more ...

Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
FDA Reclassifies Proellex(R) Clinical Hold Status: Repros to Proceed With Phase 2 Study of Low Dose Oral Proellex(R) in the Treatment of Endometriosis
RPRX  
Linked by GlobeNewswire - October 08, 09:25AM from (www.globenewswire.com)
THE WOODLANDS, Texas, Oct. 8, 2012 (GLOBE NEWSWIRE) -- Repros Therapeutics Inc.(r) (Nasdaq:RPRX) today announced the FDA  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Repros Provides Clinical Update for Androxal(R) Phase 3 Program
RPRX  
Linked by GlobeNewswire - September 12, 04:01PM from (www.globenewswire.com)

THE WOODLANDS, Texas, Sept. 12, 2012 (GLOBE NEWSWIRE) -- Repros Therapeutics Inc.(r) (Nasdaq:RPRX)today provided  more ...

Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Repros Announces the Offering of Unregistered Shares of Common Stock in the Amount of $23.6 Million
RPRX  
Linked by GlobeNewswire - September 04, 04:01PM from (www.globenewswire.com)
THE WOODLANDS, Texas, Sept. 4, 2012 (GLOBE NEWSWIRE) -- Repros Therapeutics Inc.(r) (Nasdaq:RPRX) announced today that it  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
FDA Provides Recommendations for Phase 2 Protocol for Low Dose Oral Proellex(R) in the Treatment of Endometriosis
RPRX  
Linked by GlobeNewswire - August 27, 04:01PM from (www.globenewswire.com)
THE WOODLANDS, Texas, Aug. 27, 2012 (GLOBE NEWSWIRE) -- Repros Therapeutics Inc.(r) (Nasdaq:RPRX) today announced the FDA  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Page 1 2 3 4 5 6 7 8 9



Close [X]
Select the external links you'd like on the quote and portfolio pages. We recommend 5 to 6 links. Request a new resource.
Profile/Financials
Yahoo! Profile
Yahoo! Key Stats
MSN Financials

Analysts
Nasdaq Analysts
Yahoo! Estimates
Charts / TA
Clearstation
Google Charts
StockCharts

Subscription
Insiderscore
10k Wizard
CallStreet
Other
Short Interest
SEC Filings
Insiders
Fool CAPS


Request a new resource